Is heparin plasma suitable for the determination of B-type natriuretic peptide on the Beckman-Coulter Access 2?
Authors:
- 1 February 2010
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 48 (3) , 399-401
Abstract
Background: The use of heparin as an alternative to EDTA in the production of plasma samples is of particular interest for B-type natriuretic peptide (BNP) measurements. Lithium heparin is now widely used for the determination of biochemical parameters, including cardiac markers. The goal of this study was to determine the feasibility of measuring BNP using heparin plasma instead of EDTA plasma with the Access 2 system (Beckman-Coulter). Methods: BNP was determined in heparin plasma and EDTA plasma from 24 patients within 1 h of blood collection. Additional measurements were performed with heparin plasma, every hour for the first 4 h, and then 8 h after the collection of blood that was stored at room temperature. Results: At H0, the observed BNP concentrations in heparin plasma were much higher (mean values 65% higher) than those in EDTA plasma. Using predetermined thresholds, this difference would lead to 30% discordance between samples in heparin and EDTA. BNP stability decreased over time in heparin plasma: immunoreactivity decreased approximately by 30% during the first 2 h and by 60% after 8 h. Conclusions: Heparin plasma does not seem to be a suitable alternative to EDTA plasma for measurement of BNP using the Access 2 system, even if measurements are performed immediately after blood sampling. Clin Chem Lab Med 2010;48:399–401.Keywords
This publication has 7 references indexed in Scilit:
- Stability of B-type natriuretic peptide (BNP) in whole blood and plasma stored under different conditions when measured with the Biosite Triage or Beckman-Coulter Access systemsClinica Chimica Acta, 2007
- Influence of sample matrix and storage on BNP measurement on the Bayer Advia CentaurJournal of Clinical Laboratory Analysis, 2007
- Influence of Sampling and Storage Conditions on B-Type Natriuretic Peptide Immunoreactivity for 3 Automated AssaysClinical Chemistry, 2006
- Performance Characteristics of Four Automated Natriuretic Peptide AssaysAmerican Journal of Clinical Pathology, 2005
- B-Type Natriuretic Peptide in Heart FailureCritical Pathways in Cardiology: A Journal of Evidence-Based Medicine, 2005
- Analytical and Clinical Evaluation of the Bayer ADVIA Centaur Automated B-Type Natriuretic Peptide Assay in Patients with Heart Failure: A Multisite StudyClinical Chemistry, 2004
- The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasmaClinica Chimica Acta, 2004